Mydecine Innovations Group (OTC: MYCOF), a Denver-based psychedelics research company, announced its four lead novel drug candidates on Wednesday.
The company plans to present the candidates at Pre-Investigational New Drug meetings with the FDA and Health Canada, a necessary step in obtaining approval for drug development and clinical trials.
“We are essentially taking the value that is currently present in natural molecules, such as the …
Powered by WPeMatico
